Clonidine Hydrochloride

CHEMBL1705 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

266.6 g/mol

LogP

—

Phase

4

The hydrochloride salt of clonidine, used to treat high blood pressure, ADHD, and symptoms of opioid or nicotine withdrawal by reducing nervous system activity. The salt form is stable and well-absorbed when taken orally.

Peso molecular

266,6000 g/mol

TPSA

36,40 Å²

Áreas terapéuticas

Cáncer colorrectal Cáncer de mama Cáncer de ovario Cáncer de páncreas Cáncer de próstata Cáncer de pulmón de células no pequeñas Cáncer de tiroides Cáncer de vejiga Diabetes tipo 2 Dolor crónico Endometriosis Enfermedad cardiovascular Enfermedad de Parkinson Enfermedad renal crónica Esquizofrenia Hipertensión Ictus Insomnio Insuficiencia cardíaca Manejo del dolor Obesidad Obstetricia y ginecología Trastorno bipolar Trastorno de ansiedad generalizada Trastorno depresivo mayor

Mecanismo de acción

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.Clc1cccc(Cl)c1NC1=NCCN1

InChI

InChI=1S/C9H9Cl2N3.ClH/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9;/h1-3H,4-5H2,(H2,12,13,14);1H

Molecular Formula

C9H10Cl3N3

HBD / HBA

3 / 1

Enlaces Rotables

2

Átomos Pesados

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The hydrochloride salt of clonidine, used to treat high blood pressure, ADHD, and symptoms of opioid or nicotine withdrawal by reducing nervous system activity. The salt form is stable and well-absorbed when taken orally.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Clonidine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1705. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 20179. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Clonidine Hydrochloride en PillFYI

Estructura

Datos Rápidos

Fórmula: C9H10Cl3N3
Sinónimos: 3

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.